80% of Global Commercial Fleet Leaders Surveyed Set Goal for 25% EVs by 2030, Latest Frost & Sullivan Insights Reveal LONDON, Sept. 18, 2024 /PRNewswire/ — Conducted by Frost & Sullivan and commissioned by WEX (NYSE: WEX), a new report provides key insights for organisations managing mixed-energy fleets across Europe, North America, and Asia-Pacific. The […]
Category Archives: Pr Newswire
18
Sep
Sep
HALIFAX, Nova Scotia, Sept. 17, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced the results from its annual and special meeting of shareholders held earlier today. Based on the proxies received and the […]
18
Sep
Sep
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) — $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the […]
Pr Newswire
Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
18
Sep
Sep
MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced a risk of a temporary supply disruption for EGRIFTA SV® (tesamorelin for injection) in early 2025 caused by an unexpected voluntary shutdown of the […]
18
Sep
Sep
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) — Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer drug resistance and immune suppression, announces that it has closed its initial public offering of 1,550,000 shares of common stock at an offering price […]
18
Sep
Sep
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) — The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, in which the independent directors have provided their resignation from the Board, […]
CoQuinone 100 awarded by global market researcher Euromonitor International SYDNEY, Sept. 18, 2024 /PRNewswire/ — USANA Health Sciences, Inc. is proud to announce that its Australia market was recently recognized as the number one brand of Co-enzyme Q10 by market research giant Euromonitor International. This distinction is based on market research of USANA’s CoQuinone 100 […]
ZUR YIGAL, Israel, Sept. 18, 2024 /PRNewswire/ — Helios Project Ltd., developer of the Helios Cycle™, a novel process to produce iron and other metals using sodium as a reducing agent with less energy and no direct carbon emissions, has signed a Memorandum of Understanding (MoU) with BlueScopeX Pty Ltd, a subsidiary of BlueScope Steel, a […]
Industry leaders collaborate to bring innovative approaches to evolving pharmacy needs CAMBERWELL, Australia, Sept. 18, 2024 /PRNewswire/ — MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today the launch of its Pharmacy Advisory Group. The collaboration of industry experts will offer key insights to help MedAdvisor deliver solutions to improve the medication […]
ZUR YIGAL, Israel, Sept. 18, 2024 /PRNewswire/ — Helios Project Ltd., developer of the Helios Cycle™, a novel process to produce iron and other metals using sodium as a reducing agent with less energy and no direct carbon emissions, has signed a Memorandum of Understanding (MoU) with BlueScopeX Pty Ltd, a subsidiary of BlueScope Steel, a […]